ライフサイエンスコーパス: angiogenic

1 gration and proliferation, and inhibited the angiogenic ability of ECs both in vitro and ex vivo In s

2 Thus, in addition to its angiogenic action, VEGFA upregulates Sox2 to drive stem

3 We report a pivotal role for IL-5 as an angiogenic activator.

4 lling endothelial inflammatory responses and angiogenic activities by retaining expression of TNFR-1

5 tively significant antiangiogenic and slight angiogenic activities in a microvascular sprouting assay

6 clusters that reflected the tumorigenic and angiogenic activities of the respective TMEs.

7 d to contribute via mitogenic, survival, and angiogenic activities to HHV-8-associated Kaposi's sarco

8 Y2 receptor (Y2R)-mediated proliferative and angiogenic activities.

9 down miR-126-3p from CD34Exo abolished their angiogenic activity and beneficial function both in vitr

10 ning 28 bridges endothelial inflammation and angiogenic activity by retaining expression of TNFR1 and

11 (designated EDM-TTF-1(+)) displayed an anti-angiogenic activity in the endothelial cell tube formati

12 The anti-angiogenic activity of A-LHU was investigated both in vi

13 role of TRIM28 in inflammatory responses and angiogenic activity of ECs for the first time.

14 tudy explores the fate of EETs with COX, the angiogenic activity of the primary metabolites formed, a

15 rowth factor (VEGF), characterization of its angiogenic activity, and demonstration that its expressi

16 e Stat3 inhibitor, on IFNalpha-mediated anti-angiogenic activity.

17 associated with a poor response to the anti-angiogenic agent bevacizumab in patients with colorectal

18 id (SCFA), acts classically as a potent anti-angiogenic agent in tumour angiogenesis models, some aut

19 ested sunitinib and sorafenib, two oral anti-angiogenic agents that are effective in advanced renal-c

20 ur data suggest that PCBs act as potent anti-angiogenic agents.

21 ve regulated and concerted expression of pro-angiogenic and angiostatic factors needed to produce fun

22 receptor 2, which has been shown to mediate angiogenic and blood vessel repair activities in mice.

23 f C/EBPalpha in the expansion as well as pro-angiogenic and immune suppressive functions in MDSCs.

24 ost fatal human malignancies due to its high angiogenic and infiltrative capacities.

25 Profiling screens of 153 angiogenic and inflammatory targets revealed that quinin

26 olysis; and (ii) noninvasive cells that were angiogenic and metabolically near-normal.

27 an infiltrate into tumor tissue, secrete pro-angiogenic and pro-tumorigenic factors and thereby incre

28 on of stem cell function and may explain the angiogenic and therapeutic benefits associated with CD34

29 Anti-angiogenic and vascular disrupting therapies rely on the

30 enesis and represent a novel target for anti-angiogenic and vascular normalization therapies.

31 mia-reperfusion injury, mainly by mitogenic, angiogenic, and anti-inflammatory mechanisms.

32 iRs regulate HIF-1alpha-regulated apoptotic, angiogenic, and immune pathways.

33 enocarcinomas marked by highly inflammatory, angiogenic, and immune-suppressed stroma.

34 so, we measured a panel of 12 inflammatory, angiogenic, and oxidative stress biomarkers in plasma or

35 on whether netrin-4 acts either pro- or anti-angiogenic, angiogenesis in the retina was assessed in N

36 s significantly higher GCF concentrations of angiogenic biomarkers for approximately 2 to 4 weeks and

37 euron-specific enolase, and multiple soluble angiogenic biomarkers were determined and their impact o

38 or control (N = 87) on circulating levels of angiogenic biomarkers.

39 EGF/VEGFR2 pathway activity in quiescent and angiogenic blood vascular endothelial cells, thereby pre

40 es and their exact role in the regulation of angiogenic blood vessel growth remain elusive.

41 ng peptides with significant specificity for angiogenic blood vessels and tumor cells.

42 Endothelial cell responsiveness to these pro-angiogenic BMP ligands is regulated by Notch status and

43 intain a fitness advantage over noninvasive, angiogenic (C3) cells by promoting invasion and reducing

44 Calcitriol also augmented the angiogenic capacity of MACs via the down-regulation of C

45 NFkappaB pathway, in turn triggering an anti-angiogenic cascade, might inhibit tumorigenesis and canc

46 Here we identify an angiogenic cell population for coronary artery formation

47 ts signaling events and results in excessive angiogenic cell proliferation and plexus formation, lead

48 hial pulse wave velocity (bPWV), circulating angiogenic cells (CACs), and blood pressure before and 2

49 L4/NOTCH1/VEGFA/VEGFR2 signaling axis, these angiogenic cells generate mature coronary arteries.

50 gans skin, liver, and intestines, whereas no angiogenic changes appeared due to conditioning or synge

51 ever, the Day 3 serum cultured networks were angiogenic, characterized by increased vessel density, a

52 Thus, loss of Krit1 function disables an angiogenic checkpoint to enable CCM formation.

53 Overexpression of the pro-angiogenic chemokine IL-8 (CXCL8) is associated with a p

54 n serum of human interleukin-8 (IL-8), a pro-angiogenic chemokine implicated in a wide range of infla

55 Pro-angiogenic conditions therefore drive the proliferation

56 In AMI study participants, the angiogenic cytokine platelet-derived growth factor BB gl

57 IL-37 is a novel pro-angiogenic cytokine that potently promotes endothelial c

58 The discovery of the first specific angiogenic cytokine, VEGF, in 1989 paved the way for the

59 AML cells produce pro-inflammatory and anti-angiogenic cytokines and gradually degrade endosteal end

60 s, increased production of profibrogenic and angiogenic cytokines and related alterations of the bone

61 l markers, arterial endothelial markers, pro-angiogenic cytokines, and Notch pathway components was s

62 ed to the production of pro-inflammatory and angiogenic cytokines.

63 ndwich ELISA-based assays to quantify 10 pro-angiogenic cytokines.

64 with wild-type bone marrow cells rescued the angiogenic defect and ameliorated left ventricular remod

65 Angiogenic defects caused by pericyte depletion are phen

66 orphological malformation, and led to potent angiogenic defects in zebrafish embryos.

67 Here, the anti-angiogenic drug quininib was formulated into hyaluronan

68 posits new mechanisms for understanding anti-angiogenic drug resistance and presents an expanded role

69 l tumors were sensitive to the targeted anti-angiogenic drug sunitinib but resistant to cytotoxic che

70 of tumor vascularity in response to the anti-angiogenic drug tivozanib.

71 can be treated to varying degrees with anti-angiogenic drugs, but geographic atrophy (GA) is an adva

72 derstanding angiogenesis and developing anti-angiogenic drugs, but most work only involves numerical

73 Interestingly, anti-angiogenic drugs, such as bevacizumab, when used at lowe

74 g miR-193a-3p in less proliferative and less angiogenic ECFC-derived cells will enhance their vasculo

75 rated fatty acids (PUFAs) have a highly anti-angiogenic effect in animal models.

76 Moreover, TRX80 exerts a powerful angiogenic effect in both in vitro and in vivo mouse stu

77 ous study, but the mechanisms behind the pro-angiogenic effect of IL-37 are less well understood.

78 The potent anti-angiogenic effect of miR-192 stems from its ability to g

79 used to investigate the anti-tumor and anti-angiogenic effect of SFN.

80 ver, the mechanisms by which PCBs cause anti-angiogenic effects are unclear.

81 g the Notch/Dll pathway and by inducing anti-angiogenic effects at the maternal-fetal interface.

82 Here, we evaluated PCB-mediated anti-angiogenic effects by diverse but complementary approach

83 fruit (TCMPs) have been shown to exert anti-angiogenic effects by inhibiting endothelial cell migrat

84 hat ischemia from UPI could yield protective angiogenic effects by offspring.

85 2 diabetes therapy, is associated with anti-angiogenic effects in conditions beyond diabetes.

86 to play a significant role in mediating pro-angiogenic effects of these vesicles.

87 The angiogenic effects were confirmed in IL-5-deficient mice

88 m of miR-21 mediating metformin-induced anti-angiogenic effects, providing important implications reg

89 aling in endothelial cells, with potent anti-angiogenic effects.

90 Angiogenic endothelial cells (ECs) are a major cellular

91 tor-beta co-receptor, is highly expressed on angiogenic endothelial cells in solid tumors.

92 HPMCs cultured with IL-6 and sIL-6R promoted angiogenic endothelial tube formation, which could be bl

93 e fibroblast growth factor (FGF) is a potent angiogenic factor and aberrant FGF signaling is a common

94 results demonstrate that NPNT is a paracrine angiogenic factor and may play a role in pathological os

95 tly target and repress the mRNA encoding the angiogenic factor angiopoietin 1 (ANGPT1), leading to de

96 herefore, we hypothesized that a circulating angiogenic factor could predict disease severity and sur

97 IL-32 could function as an inflammatory and angiogenic factor in human obesity and obesity-associate

98 Transient increases in angiogenic factor levels and prolonged hyperemia charact

99 wth factor-like growth factor (HB-EGF) is an angiogenic factor mediating radial migration of the deve

100 EGFL7 is a secreted angiogenic factor produced by embryonic endothelial cell

101 The activation of Akt by the potent angiogenic factor VEGF-A does not strongly stabilize mic

102 corresponding to decreased expression of the angiogenic factor VEGF.

103 AGGF1 is an angiogenic factor with therapeutic potential to treat co

104 ted the effect of miR200-b, a potential anti-angiogenic factor, on VEGF receptor 2 (VEGFR-2) expressi

105 pel-Trenaunay syndrome (KTS), and encodes an angiogenic factor.

106 eatment, and then, we assessed expression of angiogenic factors and mechanotransducers (focal adhesio

107 lue light filtering affects the secretion of angiogenic factors by retinal pigmented epithelial cells

108 In the absence of prematurity, UPI increased angiogenic factors in association with reduced OIR sever

109 y mechanotransduction-mediated expression of angiogenic factors in proximal tubular cells, and it may

110 sia (PE) are primarily driven by excess anti-angiogenic factors originating from the placenta.

111 In addition, the angiogenic factors stromal cell-derived factor 1 (SDF-1a

112 However, data regarding specific angiogenic factors that are secreted within the bone mic

113 arrow microenvironment secrete cytokines and angiogenic factors that support the maintenance and rege

114 Thrombospondin-1 (TSP-1) is one of the anti-angiogenic factors whose synthesis is driven by hypoxia.

115 tion resulted in decreased production of pro-angiogenic factors, CXCL1 and vascular endothelial growt

116 ctors, such as endostatin, and decreased pro-angiogenic factors, including CXC motif ligand 1 (CXCL1)

117 hile exhibiting increased expression of anti-angiogenic factors, such as endostatin, and decreased pr

118 Acute myeloid leukemia (AML) cells produce angiogenic factors, which likely contribute to this remo

119 g and is mediated by a plethora of potential angiogenic factors.

120 e biological processes that are regulated by angiogenic factors.

121 promoting the highest increases in EPCs and angiogenic factors.

122 Our data demonstrate a pro-angiogenic function for Wars2 both within and outside th

123 The angiogenic function of endothelial cells is regulated by

124 The impaired diabetic BMPC angiogenic function was rescued by adenovirus-mediated e

125 ulated novel lncRNA facilitating endothelial angiogenic function.

126 an essential role for PML in IFNalpha's anti-angiogenic function.

127 CFC-derived cells will enhance their vasculo/angiogenic function.

128 SP-4 shRNA, we found that TSP-4 mediated pro-angiogenic functions in cultured EC and angiogenesis in

129 imus activated Smad1/5/8 and opposed the pro-angiogenic gene expression signature associated with ALK

130 nhibition was associated with a specific pro-angiogenic gene expression signature, which included a s

131 Some angiogenic genes (VEGF, bFGF, TNF-alpha and PCNA) were u

132 ector of Vegfa signaling in the induction of angiogenic genes during sprouting.

133 ent with an MET and also revealed changes in angiogenic genes expression.

134 ven by changes in expression of several anti-angiogenic genes.

135 -1alpha protein and expression of downstream angiogenic genes.

136 ave identified Emc10 as a previously unknown angiogenic growth factor that is produced by bone marrow

137 Many angiogenic growth factors are regulated by hypoxia-induc

138 hese tumors do not depend entirely on either angiogenic growth factors or on neighboring endothelia t

139 ear polarity and migration downstream of the angiogenic growth factors VEGF-A and Slit2.

140 ss osteogenic potential and produce numerous angiogenic growth factors.

141 e and competing for the HS-binding domain of angiogenic growth factors.

142 analyzed for their potential target genes in angiogenic, hypoxic, and immune response-related pathway

143 We propose that angiogenic imbalance and residual cardiac dysfunction ma

144 ndothelial growth factor levels may imply an angiogenic imbalance that exists even after recovery and

145 tensive disorders of pregnancy often exhibit angiogenic imbalances, suggesting that the same mechanis

146 tion of C/EBPalpha in MDSCs enhanced the pro-angiogenic, immune suppressive and pro-tumorigenic behav

147 e we show that BMP6 and BMP2 ligands are pro-angiogenic in vitro and in vivo, and that lateral vessel

148 This MMRN2 peptide is anti-angiogenic in vitro and reduces tumour growth in mouse m

149 te the target genes, including cysteine-rich angiogenic inducer 61 (CYR61), connective tissue growth

150 ds (EETs) produced from the P450 pathway are angiogenic, inducing cancer tumor growth.

151 tients inevitably develop resistance to this angiogenic inhibitor.

152 The existence of anti-angiogenic isoform (VEGF165b) in PAD muscle tissues is a

153 A second set of anti-angiogenic isoforms termed VEGFAxxxb that utilise an alt

154 and COX and identifies ct-8,9-E-11-HET as an angiogenic lipid, suggesting a physiological role for CO

155 r burden and expression of proliferative and angiogenic markers was decreased in the miR-24 inhibited

156 estigate the molecular and cellular basis of angiogenic mechanisms.

157 easing the secretion of pro-invasive and pro-angiogenic mediators HTRA1, MMP1, FAM3C, PDGFA, and ADAM

158 iPSC-EVs enhanced angiogenic, migratory, and antiapoptotic properties of m

159 verexpress miR-184 secreted lower amounts of angiogenic mitogens.

160 effect of N6L has been observed in a highly angiogenic mouse model of pancreatic neuroendocrine tumo

161 or the experimentally observed dependency of angiogenic network evolution on growth-induced solid str

162 ers in vivo at high resolution throughout an angiogenic network.

163 y, and inhibiting MMPs significantly reduces angiogenic outgrowth in stiffer cross-linked gels.

164 Our data indicate that angiogenic outgrowth, invasion, and neovessel branching

165 5/8 signalling results in both pro- and anti-angiogenic outputs, highlighting a poor understanding of

166 Our results define an angiogenic pathway in which VEGF enhances ETS1-BRD4 inte

167 ms from its ability to globally downregulate angiogenic pathways in cancer cells through regulation o

168 Targeting the pro-angiogenic pathways is therefore a promising anti-glioma

169 dulating the expression of genes involved in angiogenic pathways such as VEGF (vascular endothelial g

170 onses, including vasculogenesis, alternative angiogenic pathways, and vascular mimicry.

171 of TLR9 and TLR3, TLR4, and TLR7 on the key angiogenic pathways, Fli1 and FOXO3A.

172 rowth factor (VEGF) to enable the subsequent angiogenic phase.

173 Hif2a to couple hepatocyte mitosis with the angiogenic phase.

174 d induced an inflammatory, catabolic and pro-angiogenic phenotype in bovine nucleus pulposus and cart

175 the anti-angiogenic SMC phenotype to the pro-angiogenic phenotype, which may be essential for CPEC to

176 enotype, whereas contractile SMC shows a pro-angiogenic phenotype.

177 was to assess whether ethanol, which induces angiogenic phenotypes in endothelial cells, could be emp

178 n demonstrated that physiological stimuli of angiogenic phenotypes in EV-producing cells can enhance

179 associated with declines in the survival and angiogenic potency of miPSC-ECs, and capillary and arter

180 We investigated the angiogenic potential of EMC10 and its mouse homolog (Emc

181 We have previously reported that the angiogenic potential of highly proliferative endothelial

182 via thermal oxidation method to enhance the angiogenic potential of human umbilical vein endothelial

183 ession of RPS15A in Huh7 cells increased the angiogenic potential of HUVEC in a paracrine fashion; co

184 This corresponded to an increased angiogenic potential of serum from patients with LVADs (

185 r, these studies highlight a key role of pro-angiogenic potential of transplanted osteogenic cells fo

186 osteogenic progenitor cells with higher pro-angiogenic potential significantly enhance bone repair i

187 etinal endothelial cell barrier function and angiogenic potential via activation of oxidative stress.

188 reatment significantly decreased endothelial angiogenic potential.

189 lar matrix (ECM) remodeling and insufficient angiogenic potential.

190 rowth and exhibited high tubulogenic but low angiogenic potential.

191 cellular electrical resistance and increased angiogenic potential.

192 al. identify a unique, endocardially-derived angiogenic precursor cell population for coronary artery

193 These findings show that dysregulated angiogenic precursors link coronary anomalies to ischemi

194 f corneal alloimmunity, including immune and angiogenic privilege, mechanisms of allosensitization, c

195 is of choroidal neovascularization (CNV), an angiogenic process that critically contributes to vision

196 sion and migration are critical steps of the angiogenic process, whose dysfunction is associated with

197 and mechanisms of regulation that drive the angiogenic process.

198 ood vessel formation is thought to occur via angiogenic processes involving branching from existing v

199 es, which include hypoxia, also regulate the angiogenic processes within a tumour, facilitating the s

200 d in metabolic homeostasis, inflammation, or angiogenic processes.

201 f ECFCs increased their in vitro and in vivo angiogenic properties in mice with hindlimb ischemia.

202 ndothelial cell proliferation, migration and angiogenic properties in vitro, increased postnatal reti

203 ombination with a peptidomimetic of the anti-angiogenic protein thrombospondin-1 (TSP-1 PM).

204 aged RPE also elicits elevated levels of pro-angiogenic proteins that promote ex vivo choroidal vesse

205 mination and to develop enzyme inhibitors as angiogenic regulators to treat metastasis and tumour gro

206 or example, both inflammation and inadequate angiogenic remodeling can drive fibrosis, which can in t

207 et inhibitors including cabozantinib in anti-angiogenic resistant RCC.

208 perfusion in nutrient-deprived regions where angiogenic resources are most needed.

209 a and ALK1 are required in IL-37 induced pro-angiogenic response in ECs and in the mouse model of Mat

210 ) expression and to determine the underlying angiogenic response in mouse endothelial cells, and in r

211 ure in vivo studies to direct or pattern the angiogenic response in regenerating tissues to encourage

212 miR-424 ortholog) and miR-503 have augmented angiogenic response to LPS in a Matrigel plug assay.

213 A beneficial angiogenic response to potential therapies, FK506 and El

214 Ischemia in muscle induces an angiogenic response, but the magnitude of this response

215 to attract monocytes that contribute to the angiogenic response.

216 tors of both VEGFR2 and PKCbeta1 blocked the angiogenic response.

217 ish a feedforward loop that ensures a proper angiogenic response.

218 A siRNA knockdown of HSP70-1 suppressed angiogenic responses and eNOS phosphorylation induced by

219 IL-10 expressing NK cells markedly enhanced angiogenic responses and placental development in DC exp

220 ing of IL-5 to IL-5Ralpha receptors enhances angiogenic responses by stimulating the expression of HS

221 IL-5-induced angiogenic responses depended on the binding of IL-5Ralp

222 Endothelial cell angiogenic responses in vitro and in vivo require ETS1-m

223 Angiogenic responses induced by VEGF had no effect in ei

224 The result suggests that IL-37 induces pro-angiogenic responses through TGF-beta, which may act as

225 tyrosine kinase 2 (Pyk2) in endothelial cell angiogenic responses, its role in pathological retinal a

226 IL-37 to signal through ALK1 to activate pro-angiogenic responses.

227 HSP70-1 overexpression enhanced IL-5-induced angiogenic responses.

228 t is putatively involved in GPR124-dependent angiogenic responses.

229 The results underscore the angiogenic role of FRS2alpha-mediated signaling in tumor

230 However, non-angiogenic roles of NRP1 in tumor progression remain poo

231 complex subunit 10), showing activity in an angiogenic screen.

232 onents and the role of VEGF in modifying the angiogenic secretome.

233 ces were observed between the TIF and plasma angiogenic secretomes in triple negative MDA-MB-231 brea

234 ing of EC metabolism, how it intersects with angiogenic signal transduction, and how alterations in m

235 mor compartment whose volume depends on the "angiogenic signal" produced when VEGF binds to its recep

236 herapy may be driven by restoration of renal angiogenic signaling and attenuated fibrogenic activity,

237 e factors, and genomic mutations that hijack angiogenic signaling and drive malignant growth.

238 owth factor (PlGF) in the body and resulting angiogenic signaling is not well-understood.

239 Most studies of its angiogenic signaling mechanisms have been in endothelial

240 Here, in a striking parallel to tumor pro-angiogenic signaling, we identify angiopoietin-2 (ANG-2)

241 Besides an increase in the production of pro-angiogenic signals such as vascular endothelial growth f

242 poxia also stimulates the production of anti-angiogenic signals.

243 In summary, quininib is a novel anti-angiogenic small-molecule CysLT receptor antagonist.

244 e a potent stimulator for switching the anti-angiogenic SMC phenotype to the pro-angiogenic phenotype

245 concept that synthetic SMC exhibits an anti-angiogenic SMC phenotype, whereas contractile SMC shows

246 small interfering RNAs or GapmeRs inhibited angiogenic sprouting and alignment of endothelial cells

247 ic device to study chemokine gradient-driven angiogenic sprouting and find that matrix degradability

248 amily 14 member A (CLEC14A) display enhanced angiogenic sprouting and hemorrhage as well as enlarged

249 We analyzed the data collected in-situ from angiogenic sprouting experiments and identified the diff

250 angiogenic tubule formation in HMEC-1 cells, angiogenic sprouting in aortic ring explants, and retina

251 y delayed healing of skin wounds and reduced angiogenic sprouting in subcutaneous matrigel plugs.

252 Here, we show that angiogenic sprouting into the injured area starts as ear

253 d interaction regulates barrier function and angiogenic sprouting through different mechanisms.

254 successfully formed monolayers and underwent angiogenic sprouting within 7 days in culture.

255 leukocytes extravasated from limbal vessels, angiogenic stalks, and growing tip vessels and migrated

256 ecretion of VEGF downstream of the two major angiogenic stimuli occurring during pressure overload br

257 operties that influence the response to anti-angiogenic strategies.

258 acity, having osteogenic potential (PC-O) or angiogenic support function (PC-M), while lacking adipog

259 The angiogenic switch is an important oncogenic step that de

260 proangiogenic function, which inhibited the angiogenic switch necessary for malignant progression of

261 -17-92 cluster expression contributes to the angiogenic switch of ECs and participates in the regulat

262 This study reveals a layer in the angiogenic switch of pNETs and identifies a therapeutic

263 tate stroma is critical for activation of an angiogenic switch that fuels exponential tumor growth.

264 xis ultimately leads to the induction of the angiogenic switch through the positioning of proangiogen

265 east tumorigenesis or to trigger the tumoral angiogenic switch.

266 knockout results in an additive reduction in angiogenic switching, whereas at late stages, several tu

267 onuclear ZO-1 pattern was significantly more angiogenic that that without detectable cytonuclear ZO-1

268 The model is then utilized to simulate anti-angiogenic therapeutic interventions targeting VEGFR2-ER

269 biologics that have been used in ocular anti-angiogenic therapeutic regimes.

270 kely contribute to this remodeling, but anti-angiogenic therapies do not improve AML patient outcomes

271 Anti-angiogenic therapies for cancer such as VEGF neutralizin

272 ovide strong implications for designing anti-angiogenic therapies that may differentially target endo

273 regulation is needed to improve current anti-angiogenic therapies.

274 low molecular weight heparin (LMWH) in anti-angiogenic therapy has been tempered by poor in vivo del

275 18 pathway may be a rational target for anti-angiogenic therapy of HCC.

276 t is likely that acquired resistance to anti-angiogenic therapy will involve alterations of the tumor

277 y being explored in clinical trials for anti-angiogenic therapy.

278 Here, we show that a key angiogenic transcriptional factor hypoxia-inducible fact

279 However, the angiogenic transcriptional program is reduced when miR-1

280 owth kinetics influence the response to anti-angiogenic treatment targeting VEGF.

281 rately predicts the tumor's response to anti-angiogenic treatment.

282 Upregulation of pro-angiogenic TSP-4 and selective effects of TSP-4 on EC ma

283 ith either full-length TSP1 or 3TSR, an anti-angiogenic TSP1 fragment, suppresses heightened vascular

284 0 mumin zebrafish and significantly inhibits angiogenic tubule formation in HMEC-1 cells, angiogenic

285 ivity in vessels of patient-derived FVMs and angiogenic tufts in the retina of mice with oxygen-induc

286 cale, in-silico model of dynamically coupled angiogenic tumour growth is specified to in-vivo and in-

287 estimates and inverse correlation with anti-angiogenic tyrosine-kinase inhibition in comparison to p

288 The angiogenic up-regulation of sFRP1 overexpression were fu

289 vel therapeutic targets for the treatment of angiogenic vascular disorders.

290 served time-varying spatial distributions of angiogenic vasculature.

291 Outside the breeding season (BS), angiogenic VEGF-A stimulates vessel growth in the infund

292 Concentrations of angiogenic (VEGF-A, Ang1, Ang2), anti-angiogenic (VEGF-A

293 ons of angiogenic (VEGF-A, Ang1, Ang2), anti-angiogenic (VEGF-A165b ) and lymphangiogenic (VEGF-C) fa

294 inflammatory (IL-1beta and TNFalpha) and pro-angiogenic (VEGFA) genes expressed by mast cells, and mi

295 Mother vessels (MV) are the first angiogenic vessel type to form in tumors and after Ad-VE

296 The accumulated CtsB(-/-) leukocytes in angiogenic vessels expressed more CD18.

297 leukocytes accumulated in a higher number in angiogenic vessels, but extravasated less toward the imp

298 itates the homing of targeted NPs to adipose angiogenic vessels, thereby amplifying their delivery.

299 hedding regulates leukocyte recruitment from angiogenic vessels.

300 e cytokines, indicating immune competence of angiogenic vessels.